EMA Reflection Paper provides Concrete Information about Risk based Quality Management
In the GMP News from 28 September 2011
we announced the publication of EMA's "Reflection paper on risk based quality management in clinical trials". The 31-page document is a draft to be commented. It gets very interesting from page 14 on which presents an Annex 1 entitled "Points to consider when establishing a risk based quality management approach". Annex 1 is composed of a table which shows the points to consider for the risk identification and examples of how to control them and eventually mitigation and/or acceptance solutions. Clinical studies are - of course - a focus. However, the table is also interesting for other fields - e.g. following risks are discussed:- Contract issues
- Project Management
- Personnel Qualification
- Quality Control Documentation
- Deviations
- GMP Compliance
Conclusion: Although the focus is on clinical studies, it is interesting to read about EMA's specific positions regarding risk control. The question is what the final document will look like? Now, it is already clear that risk based quality management will play a more significant role.
Author:
Sven Pommeranz
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
12.02.2025Is "right-sizing" GMP and Compliance (Lean GMP) possible?
12.02.2025Update of Training Material for ICH Q8, Q9 and Q10
05.02.2025European Shortages Monitoring Platform (ESMP) goes live
05.02.2025The ICH Q9 Briefing Package - a Forgotten Document?
23.01.2025FDA proposes Standardized Testing for Asbestos in Talc-Containing Cosmetic Products
16.01.20252nd Version of the Union list of Critical Medicines published